PURPOSE:To provide a Hashimoto strumitis-treating agent containing N-(2- carboxyphenyl)-4-chloroanthranilic acid or a salt thereof as an active ingredient, capable of reducing the supply of symptomatic therapeutic agents and contracting goiters and effective for the recovery, etc., of the functions of thyroid glands. CONSTITUTION:The agent contains N-(2-carboxyphenyl)-4-chloroanthranilic acid or a salt thereof (e.g. sodium or potassium salt) as an active ingredient. The active ingredient is generally orally administered in a dose of 50-400mg/adult.day, preferably 80-320mg/adult.day, for the Hashimoto strumitis. The active ingredient is administered as an oral agent, injection agent, etc., for the treatment of the Hashimoto strumitis.
展开▼
